Breaking News

CureVac, Rentschler Ramp up COVID Vax Production

Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CureVac N.V. and Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, initiated the set-up of manufacturing capabilities for CureVac´s COVID-19 vaccine, CVnCoV.   Rentschler Biopharma is preparing for largescale cGMP production of the formulated mRNA for CVnCoV. CureVac began the clinical Phase 2b/3 trial with its mRNA-based vaccine candidate against SARS-CoV-2, and is preparing the start of commercial production to meet global demands.   Rentschler Biopharma contributes to the man...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters